Xu et al. conducted an inquiry into the involvement of miR-29 s in glioblastoma, wherein they provided evidence supporting the effective suppression of DNMT3B expression through mRNA degradation mediated by miR-29s in the U87MG glioblastoma cell line. The gene discussed is DNMT3B; the disease is glioblastoma.